NCT04421924 Periinterventional Coagulation Management of Patients Undergoing a TIPS
| NCT ID | NCT04421924 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Graz |
| Condition | Liver Cirrhosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 39 participants |
| Start Date | 2020-05-27 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 39 participants in total. It began in 2020-05-27 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Assess whether a pre-interventional thrombelastography guided algorithm for assessing and correction of coagulation status in cirrhotic patients is safe and effective
Eligibility Criteria
inclusion criteria * Liver cirrhosis * \>18 years * Indication for TIPS implantation * Ability to sign informed consent exclusion criteria * Contraindications against TIPS implantation * Hepatocellular carcinoma BCLC D * Ongoing bleeding * pre-existing anticoagulant therapy at time of inclusion * administration of blood products within 1 week prior to the enrolment * Other malignancies that lead to an impaired 90-day survival * Inherit blood clotting disorders * Hepatic encephalopathy grade 3 or 4 * any other condition or circumstance, which, in the opinion of the investigator, would affect the patient's ability to participate in the protocol
Frequently Asked Questions
Who can join the NCT04421924 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Liver Cirrhosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04421924 currently recruiting?
Yes, NCT04421924 is actively recruiting participants. Visit ClinicalTrials.gov or contact Medical University of Graz to inquire about joining.
Where is the NCT04421924 trial being conducted?
This trial is being conducted at Graz, Austria.
Who is sponsoring the NCT04421924 clinical trial?
NCT04421924 is sponsored by Medical University of Graz. The trial plans to enroll 39 participants.